Many studies have shown that myelin in the central nervous system strongly inhibits the regeneration of axons, so it comes as a surprise to discover that adult neurons transplanted into the brain rapidly extend their axons through myelinated pathways. Why do severed axons of the central nervous system (CNS) fail to regenerate, given that severed axons of the peripheral nervous system (PNS) rapidly re-extend and re-innervate their targets [1]? The explanation for this extraordinary observation is crucial to understanding why our brains and spinal cords do not repair themselves after injury. Two general classes of explanation have been put forth to help account for the remarkable difference in the ability of CNS and PNS axons to regenerate. There may be fundamental differences between CNS and PNS neurons, or between CNS and PNS glia (or both).
Why do severed axons of the central nervous system (CNS) fail to regenerate, given that severed axons of the peripheral nervous system (PNS) rapidly re-extend and re-innervate their targets [1] ? The explanation for this extraordinary observation is crucial to understanding why our brains and spinal cords do not repair themselves after injury. Two general classes of explanation have been put forth to help account for the remarkable difference in the ability of CNS and PNS axons to regenerate. There may be fundamental differences between CNS and PNS neurons, or between CNS and PNS glia (or both).
Although it was once believed that CNS neurons intrinsically lack the ability to regenerate, this view was elegantly disproved by the experiments of Albert Aguayo and his colleagues, who showed that at least some retinal ganglion cells (RGCs) could regenerate their axons through fragments of peripheral nerve grafted into their central pathways [2] . Moreover, whereas the peripheral processes of dorsal root ganglion (DRG) neurons rapidly regenerate down peripheral nerves when severed, the central processes of these same neurons are unable to regenerate into the CNS [1] . These observations suggest that there may be important differences between the ability of CNS and PNS glia to support regeneration. In the PNS, Schwann cells are the main glial cell type, whereas CNS glia include both astrocytes and oligodendrocytes.
This possibility has received strong support from the studies of Schwab and colleagues [3] [4] [5] , who showed that oligodendrocytes express membrane proteins of 35 kDa and 250 kDa that are present in CNS myelin and that strongly inhibit the growth of axons of cultured DRG neurons. In the PNS, Schwann cell myelin does not contain these proteins. The monoclonal antibody IN-1 neutralizes the 35 kDa and 250 kDa CNS myelin molecules and allows axons to grow over the oligodendrocytes in vitro and, to a lesser degree, in vivo in a cut spinal cord regeneration model [4, 5] . Presumably, these signals would not be inhibitory to growing axons during development, either because embryonic neurons lack receptors for these inhibitory molecules or because normally most oligodendrocytes do not develop until after target innervation; in fact, it has been shown previously that embryonic neurons transplanted into the CNS can successfully regenerate their axons down myelinated pathways [6] .
Thus it now comes as a great surprise to learn that adult DRG neurons transplanted into myelinated regions of adult brain can, in fact, rapidly regenerate their axons, demonstrating that myelinated pathways are permissive for regeneration after all [7] . When Jerry Silver and his colleagues transplanted DRG neurons into the brain, into either the corpus callosum or the fimbria, they found axons coursing through the myelin at rates of 1-2 mm per day [7] , a rate equal to that seen during development and during PNS regeneration. By 6 days after the transplant, 80% of the transplanted axons reaching the midline extended as far as the contralateral white-grey matter interface of the rostrum of the corpus callosum, and their axons were observed to branch into terminal arbors, which the authors suggested could reflect donor innervation of host grey matter.
So why weren't the axons of the DRG neurons inhibited by myelin-associated inhibitory proteins? One obvious possibility is that the axons simply avoided them by migrating along other cell types, such as astrocytes, instead of along myelin (as shown for neuron A in Figure 1 ). In contrast, DRG axons had no astrocyte-mediated bridging path to enable them to avoid oligodendrocytes in previous culture studies, because the cultures lacked astrocytes [8] . The electron microscopic studies necessary to address this issue have not yet been performed for the present experiments [7] .
A second possibility is that the axons did extend along the myelin but were not inhibited because the inhibitory proteins are not normally located in the abaxonal (outer) myelin surface (neuron B in Figure 1 ). Another myelin inhibitory protein, myelin-associated glycoprotein (MAG) [9, 10] , is clearly localized primarily adaxonally (next to the axon); the localization of the IN-1 epitopes within myelin is not yet known. This is an important possibility, because many previous experiments demonstrating a myelin inhibition in vivo have involved injuries that disrupted myelin, possibly exposing normally unexposed inhibitory proteins. Similarly, in vitro experiments using cultured oligodendrocytes or myelin extracts may expose such inhibitors. If only disrupted and not normal myelin is inhibitory, the microtransplantation technique of Silver and colleagues [7] may have avoided exposing such inhibitory cues. Finally, it is possible that the myelin inhibition was present in vivo but was outweighed by facilitatory influences from astrocytes or other cell types (neuron C in Figure 1 ). It will be important to distinguish among such possibilities in future experiments.
If myelin does not inhibit the outgrowth of CNS axons in vivo,
what is responsible for the consistent failure of CNS regeneration? Astrocytes are present in the CNS but not the PNS, and could in certain cases inhibit growing axons. Injury to the CNS is normally accompanied by local activation of astrocytes, which form thick cellular scars at sites of traumatic damage that could potentially impede axon growth [11] . When activated at the site of injury, astrocytes upregulate expression of a number of extracellular matrix molecules including tenascin, keratin, and chondroitin sulfate proteoglycans (CSPGs), all of which have been shown to inhibit growing axons [12] . Both developmentally and in the case of CNS injury, CSPG expression correlates with the cessation of axon growth and failure to regenerate [13] . Silver and colleagues found that in the seven transplanted animals that showed no axon growth into adjacent host white matter, there was an upregulation of proteoglycan staining at the boundaries of the transplant [7] . Furthermore, in transplanted animals showing successful regeneration, axon growth aborted in areas expressing increased levels of CSPGs. Taken together, these results suggest that astrocyte-associated extracellular matrix molecules may play a more significant inhibitory role in vivo than cell-mediated inhibition by oligodendrocytes or myelin. It remains to be explored which CSPGs, or which other co-localized molecules, are responsible for restriction in vivo. Robust axonal regeneration of adult neurons in the presence of bridging pathways that allow avoidance of reactive astrocytes and disrupted myelin has also been observed in other recent experiments [14, 15] .
These new experiments [7] also illustrate the difficulty in understanding why CNS axons do not regenerate, which is that the problem is likely to be multifactorial. For instance, the contribution of intrinsic differences between CNS and PNS neurons, which has not been addressed in these experiments, is likely to be important. Even in experiments that have shown successful regeneration of axons in the CNS when inhibitory influences are lessened, the vast majority of axons still did not regenerate. Many CNS axons die when their axons are severed, whereas PNS neurons do not. Indeed, peripheral nerve grafts may first increase neuronal survival and only then facilitate axonal regeneration. Consistent with this possibility, grafting a peripheral nerve into the vitreous of the eye, where it can provide only survival signals to RGCs, increases the level of RGC regeneration [16] . Likewise, when the survival of a population of central neurons (RGCs) was promoted by transgenic overexpression of the anti-apoptotic protein Bcl-2, their ability Dispatch R311
Figure 1
How did adult DRG neurons regenerate their axons along myelinated CNS pathways in vivo? Perhaps (as indicated by neuron A) DRG axons grew along cell types other than oligodendrocytes -such as astrocytes; or (as for neuron B) myelin-associated inhibitors (brown pyramids) might be masked in nondisrupted tissues if they are normally expressed next to the axons only; or finally, (for neuron C) facilitatory factors may be sufficient in vivo to overcome other exposed inhibitory epitopes (pink cubes). to regenerate was significantly improved [17] . The relatively lower ability of CNS neurons to regenerate may thus reflect, in part, that the signals necessary to promote the survival and growth of many types of CNS and PNS neurons are fundamentally different [18] .
Thus, the Silver lab's use of DRG neurons [7] was a brilliant choice: given that adult DRG neurons promote their own survival with autocrine signals [19] , extrinsic influences on axonal growth could be investigated without issues of neuronal survival confounding the results. If an intrinsic difference in survival control is a major contributor to the failure of CNS axon regeneration, experiments using CNS cell populations may not be comparable, and solving the problem of DRG growth in CNS tissues may not fully address the issues involved in solving the regeneration problem in other neuronal populations. Thus, it will be of great interest in future experiments to examine whether adult CNS neurons that overexpress Bcl-2 have a similarly improved capacity for regeneration when transplanted into CNS myelinated pathways. In any case, the exciting new experiments of Silver and his colleagues [7] suggest that although myelin exerts a powerful inhibitory influence in vitro, the problems of promoting axonal regeneration in vivo will probably not prove to be insurmountable.
